1[1]Turner J,Corrah T,Sabbally S,et al.A Longitudinal study of in vitro IFN-γ production and cyctoxic T cell response of tuberculosis patients in the Gambia[J].Tuberc Lung Dis,2000,80 (3):161-169
3[3]SoruriA,Schweyer S,Radzun HJ,et al.Mycobacterial antigens induce apoptosis in human purified proteinderivative-specific alphabeta T lymphocyctes in a concentration-dependent manner[J].Immunology,2002,105:222-230
1Polak Wyss A, Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on cryptococcus and Aspergillus infections in normal and immunosuppressed mice [J]. mycoses, 1991,34(5/6) :205 - 215.
2Kwakami K, Qureshi M H, Zhang T T, et al. Interferon-gamma(IFN-γ)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans [ J ]. Clin Exl Immunol,1999,117(1) :113- 122.
3Murray H W. Interferon-gamma and host antimicrobial defense:current and future clinical applications [J]. Am J Med, 1994,97(5) :459 - 467.
4Kobayashi K, Nakata N, Kai M, et al. Decreased expression of cytokines that induce type 1 helper T cell/interferon-γ responses in genetically susceptible mice infected with Mycobacterium avium [J].Clin Immunol Immunopethol, 1997,85( 1 ) : 112- 116.
5Turner J, Corrah T, Sabbally S, et al. A longitudinal study of in vitro IFN-γProduction and cytotoxic T cell responses of tuberculosis patients in the Gambia [J]. Tuberc Lung Dis,2000, 80(3) : 161-169.
6Wang J, Wakeham J, Harknees R, et al. Macrophages are a significant source of type 1 cytokines during mycobacterial infection [J].J Clin Invest, 1999,103(7):1023- 1029.
7Condos R, Bom W N, Schluger N W. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol [J].Lancet, 1997,349 (9064) : 1513-1515.
3World Health Organization. Global tuberculosis control -epidemio!o- gy, strategy, financin[R/OL]. World Health Organization Report 2009. WHO/HTM/TB/2009. 411. http://www, who. int/tb/publica- tions/global-reporff2009/en]index, html.
4Yew WW, Leung CC. Update in tuberculosis 2008[J]. Am J Respir Crit Care Med,2009. 179(5):337-343.
5Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis[J]. Immunol Rev ,2008,226: 191-204.
6Kaufmann SH, Baumarm S, Nasser Eddine A. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis [J]. Int. J. Tuberc. LungDis,2006,10(10):1068-1079.
7Flgnn JL, Chun J, Triebold KJ, et al. An essential role for interfer- on-γ in resistance to mycobacterium tuberculosis infection[J]. J Exp Med, 1993,178(6) : 2249-2254.
8Sallakei N, Coskun. M, Berber Z, et al. Interferon-gamma gene + 874T-A polymorphism is associated with tuberculosis and gamma in- terferon response[J]. Tu-bemulosis(Edinb), 2007,87: 225-230.
9Moran A,Ma X,Reieh RA,et al. No association between the +874T/ A single nueleotide polymorphism in the IFN-gamma gene and sus- eeptibilitytoTB[J]. Int. J. Tubere. Lung Dis,2007,11:113-115.
10Selvaraj P, Alagarasu K, Harishankar M, et al. Cytokine gene poly- morphisms and cytokine levels in pulmonary tuberculosis[J]. Cyto- kine, 2008 : 26-33.
